Danhong Zhou
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Danhong Zhou has a total of 89 co-authors. Here are the top co-authors by number of shared publications:
- Xiaojun Peng
Dalian University of Technology
8 shared publications - Jiangli Fan
Dalian University of Technology
5 shared publications - Jianjun Du
Dalian University of Technology
4 shared publications - Wen Sun
Dalian University of Technology
4 shared publications Tian Qiu
State Key Laboratory of Fine Chemicals Frontiers Science Center for Smart Materials Oriented Chemical Engineering Dalian University of Technology Dalian China
3 shared publicationsChengyuan Lv
2 shared publications
Latest Publications
- Open Access
- 21 October 2026
- Published by Elsevier in SSRN Electronic Journal
Dual-Channel TADF and RTP in a Difluoroboron β-Diketonate Host–Guest System for Organic Long Afterglow
Purely organic long-persistent luminescence materials capable of efficiently utilizing triplet excitons through multiple radiative pathways remain difficult to realize because triplet generation, stabilization, and recycling must be simultaneously regulated. Herein, a melt-processable host–guest afterglow system is constructed by dispersing a fluorene-containing difluoroboron β-diketonate luminophore, 3-OMe, into a crystalline 4-methoxybenzophenone (MeOBP) matrix. The rigid MeOBP matrix suppresses molecular motions and nonradiative deactivation, thereby enabling long-lived guest-centered emission. The optimized material exhibits a bright yellow afterglow visible for more than 5 seconds under ambient conditions and two delayed-emission bands located at approximately 480-500 and 540-545 nm. Temperature-dependent spectroscopy and decay measurements assign the shorter-wavelength emissions predominantly to thermally activated delayed fluorescence and the longer-wavelength emissions to room-temperature phosphorescence. The apparent intersystem crossing and reverse intersystem crossing rate constants are estimated to be approximately 7.70 – 8.96 × 107 s-1 and 10.24 – 11.93 s⁻¹, respectively. Moreover, the material can be readily processed into powders, patterned films, and aqueous dispersions, demonstrating the potential of controlled triplet-exciton recycling for constructing efficient and processable organic afterglow materials.
- 21 October 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessDual-Channel TADF and RTP in a Difluoroboron β-Diketonate Host–Guest System for Organic Long Afterglow
Purely organic long-persistent luminescence materials capable of efficiently utilizing triplet excitons through multiple radiative pathways remain difficult to realize because triplet generation, stabilization, and recycling must be simultaneously regulated. Herein, a melt-processable host–guest afterglow system is constructed by dispersing a fluorene-containing difluoroboron β-diketonate luminophore, 3-OMe, into a crystalline 4-methoxybenzophenone (MeOBP) matrix. The rigid MeOBP matrix suppresses molecular motions and nonradiative deactivation, thereby enabling long-lived guest-centered emission. The optimized material exhibits a bright yellow afterglow visible for more than 5 seconds under ambient conditions and two delayed-emission bands located at approximately 480-500 and 540-545 nm. Temperature-dependent spectroscopy and decay measurements assign the shorter-wavelength emissions predominantly to thermally activated delayed fluorescence and the longer-wavelength emissions to room-temperature phosphorescence. The apparent intersystem crossing and reverse intersystem crossing rate constants are estimated to be approximately 7.70 – 8.96 × 107 s-1 and 10.24 – 11.93 s⁻¹, respectively. Moreover, the material can be readily processed into powders, patterned films, and aqueous dispersions, demonstrating the potential of controlled triplet-exciton recycling for constructing efficient and processable organic afterglow materials.
- Open Access
- 30 September 2026
- Published by Wiley in Advanced Functional Materials
- Vol. 36 (91) , e78845
An Asymmetric D–A–D' Decoupling Strategy Enables Organic Scintillator‐Photocatalyst Integration for Temperature‐Adaptive and Conformal X‐Ray Imaging
High performance X‐ray imaging in extreme environments requires scintillators with robust luminescence across a wide temperature range. To address this, we propose an asymmetric “donor‐acceptor‐donor'” (D–A–D') decoupled strategy to integrate organic temperature‐adaptive scintillator and photocatalyst functionalities into a single molecule. This approach enables precise, temperature‐dependent regulation of intersystem crossing (ISC) and reverse intersystem crossing (RISC) to achieve phosphorescence at low temperatures and thermally activated delayed fluorescence (TADF) at ambient and elevated temperatures. The resulting scintillator maintains efficient and stable luminescence from 80 to 480 K. Particularly, its photocatalytic capability drives photopolymerization to in situ encapsulate itself within the polymer matrix, enhancing the scintillation performance. The transparent photocured films achieve conformal contact with targets, showing a low detection limit of 2.11 µGy s −1 (lower than the standard dosage of 5.5 µGy s −1 for X‐ray diagnostics) and spatial resolution exceeding 25 lp mm −1 at room temperature. Finally, we demonstrate its practical potential through variable‐temperature X‐ray imaging. This study extends the temperature‐adaptive operational range of organic scintillators, thereby facilitating the advancement of X‐ray imaging technologies for extreme‐environment applications.
- 30 September 2026
- Published by Wiley in Advanced Functional Materials
- Vol. 36 (91) , e78845
Open AccessAn Asymmetric D–A–D' Decoupling Strategy Enables Organic Scintillator‐Photocatalyst Integration for Temperature‐Adaptive and Conformal X‐Ray Imaging
High performance X‐ray imaging in extreme environments requires scintillators with robust luminescence across a wide temperature range. To address this, we propose an asymmetric “donor‐acceptor‐donor'” (D–A–D') decoupled strategy to integrate organic temperature‐adaptive scintillator and photocatalyst functionalities into a single molecule. This approach enables precise, temperature‐dependent regulation of intersystem crossing (ISC) and reverse intersystem crossing (RISC) to achieve phosphorescence at low temperatures and thermally activated delayed fluorescence (TADF) at ambient and elevated temperatures. The resulting scintillator maintains efficient and stable luminescence from 80 to 480 K. Particularly, its photocatalytic capability drives photopolymerization to in situ encapsulate itself within the polymer matrix, enhancing the scintillation performance. The transparent photocured films achieve conformal contact with targets, showing a low detection limit of 2.11 µGy s −1 (lower than the standard dosage of 5.5 µGy s −1 for X‐ray diagnostics) and spatial resolution exceeding 25 lp mm −1 at room temperature. Finally, we demonstrate its practical potential through variable‐temperature X‐ray imaging. This study extends the temperature‐adaptive operational range of organic scintillators, thereby facilitating the advancement of X‐ray imaging technologies for extreme‐environment applications.
- 28 September 2026
- Published by Wiley in Angewandte Chemie
- Vol. 138 (46) , e6505397
Excited‐State Structural Distortion of Pentamethine Chains Enhances Singlet Oxygen Generation as a Photoimmunotherapeutic Agent
The structural design of photosensitizers (PSs) has a significant impact on the intersystem crossing (ISC) and reactive oxygen species (ROS) generation and photodynamic performance. However, current studies of PSs for increasing ROS yield mainly focus on the ground‐state configuration, ignoring the influence of the excited‐state distorted configuration. In this work, we designed a distorted pentamethine chain structure in the excited state with a rotatable, large steric hindrance electron‐withdrawing group (ethylbenzothiazole) in the meso‐position ( Cy‐S‐Y ). Due to a new strategy of structural distortion‐enhanced intersystem crossing (SDE‐ISC), Cy‐S‐Y exhibited a superior capacity for singlet oxygen ( 1 O 2 ) generation ( 1 O 2 quantum yield ( Φ Δ ) = 44.7%) with low light power (3 mW/cm 2 ) in H 2 O, outperforming the Cy‐Br modified with heavy atoms (8.4‐fold). Theoretical calculations confirmed that Cy‐S‐Y had a distorted pentamethine chain structure in the T 2 state, resulting in a small energy gap (Δ E S1‐T2 = ‐0.002 eV) and a large spin‐orbit coupling constant (SOC = 0.29 cm −1 ), thereby promoting efficient ISC. In addition, Cy‐S‐Y ‐mediated photoimmunotherapy promoted damage‐associated molecular patterns (DAMPs) and released immune‐stimulating factors in vitro. As a result, Cy‐S‐Y not only inhibited tumor growth but also improved the immune microenvironment and significantly prolonged survival in a tumor‐bearing mouse model.
- 28 September 2026
- Published by Wiley in Angewandte Chemie
- Vol. 138 (46) , e6505397
Excited‐State Structural Distortion of Pentamethine Chains Enhances Singlet Oxygen Generation as a Photoimmunotherapeutic Agent
The structural design of photosensitizers (PSs) has a significant impact on the intersystem crossing (ISC) and reactive oxygen species (ROS) generation and photodynamic performance. However, current studies of PSs for increasing ROS yield mainly focus on the ground‐state configuration, ignoring the influence of the excited‐state distorted configuration. In this work, we designed a distorted pentamethine chain structure in the excited state with a rotatable, large steric hindrance electron‐withdrawing group (ethylbenzothiazole) in the meso‐position ( Cy‐S‐Y ). Due to a new strategy of structural distortion‐enhanced intersystem crossing (SDE‐ISC), Cy‐S‐Y exhibited a superior capacity for singlet oxygen ( 1 O 2 ) generation ( 1 O 2 quantum yield ( Φ Δ ) = 44.7%) with low light power (3 mW/cm 2 ) in H 2 O, outperforming the Cy‐Br modified with heavy atoms (8.4‐fold). Theoretical calculations confirmed that Cy‐S‐Y had a distorted pentamethine chain structure in the T 2 state, resulting in a small energy gap (Δ E S1‐T2 = ‐0.002 eV) and a large spin‐orbit coupling constant (SOC = 0.29 cm −1 ), thereby promoting efficient ISC. In addition, Cy‐S‐Y ‐mediated photoimmunotherapy promoted damage‐associated molecular patterns (DAMPs) and released immune‐stimulating factors in vitro. As a result, Cy‐S‐Y not only inhibited tumor growth but also improved the immune microenvironment and significantly prolonged survival in a tumor‐bearing mouse model.
- 28 September 2026
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 65 (46)
Excited‐State Structural Distortion of Pentamethine Chains Enhances Singlet Oxygen Generation as a Photoimmunotherapeutic Agent
The structural design of photosensitizers (PSs) has a significant impact on the intersystem crossing (ISC) and reactive oxygen species (ROS) generation and photodynamic performance. However, current studies of PSs for increasing ROS yield mainly focus on the ground‐state configuration, ignoring the influence of the excited‐state distorted configuration. In this work, we designed a distorted pentamethine chain structure in the excited state with a rotatable, large steric hindrance electron‐withdrawing group (ethylbenzothiazole) in the meso‐position ( Cy‐S‐Y ). Due to a new strategy of structural distortion‐enhanced intersystem crossing (SDE‐ISC), Cy‐S‐Y exhibited a superior capacity for singlet oxygen ( 1 O 2 ) generation ( 1 O 2 quantum yield ( Φ Δ ) = 44.7%) with low light power (3 mW/cm 2 ) in H 2 O, outperforming the Cy‐Br modified with heavy atoms (8.4‐fold). Theoretical calculations confirmed that Cy‐S‐Y had a distorted pentamethine chain structure in the T 2 state, resulting in a small energy gap (Δ E S1‐T2 = ‐0.002 eV) and a large spin‐orbit coupling constant (SOC = 0.29 cm −1 ), thereby promoting efficient ISC. In addition, Cy‐S‐Y ‐mediated photoimmunotherapy promoted damage‐associated molecular patterns (DAMPs) and released immune‐stimulating factors in vitro. As a result, Cy‐S‐Y not only inhibited tumor growth but also improved the immune microenvironment and significantly prolonged survival in a tumor‐bearing mouse model.
- 28 September 2026
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 65 (46)
Excited‐State Structural Distortion of Pentamethine Chains Enhances Singlet Oxygen Generation as a Photoimmunotherapeutic Agent
The structural design of photosensitizers (PSs) has a significant impact on the intersystem crossing (ISC) and reactive oxygen species (ROS) generation and photodynamic performance. However, current studies of PSs for increasing ROS yield mainly focus on the ground‐state configuration, ignoring the influence of the excited‐state distorted configuration. In this work, we designed a distorted pentamethine chain structure in the excited state with a rotatable, large steric hindrance electron‐withdrawing group (ethylbenzothiazole) in the meso‐position ( Cy‐S‐Y ). Due to a new strategy of structural distortion‐enhanced intersystem crossing (SDE‐ISC), Cy‐S‐Y exhibited a superior capacity for singlet oxygen ( 1 O 2 ) generation ( 1 O 2 quantum yield ( Φ Δ ) = 44.7%) with low light power (3 mW/cm 2 ) in H 2 O, outperforming the Cy‐Br modified with heavy atoms (8.4‐fold). Theoretical calculations confirmed that Cy‐S‐Y had a distorted pentamethine chain structure in the T 2 state, resulting in a small energy gap (Δ E S1‐T2 = ‐0.002 eV) and a large spin‐orbit coupling constant (SOC = 0.29 cm −1 ), thereby promoting efficient ISC. In addition, Cy‐S‐Y ‐mediated photoimmunotherapy promoted damage‐associated molecular patterns (DAMPs) and released immune‐stimulating factors in vitro. As a result, Cy‐S‐Y not only inhibited tumor growth but also improved the immune microenvironment and significantly prolonged survival in a tumor‐bearing mouse model.
- Open Access
- 15 April 2026
- Published by Elsevier in SSRN Electronic Journal
Multiple-Resonance Extension and Long-Range Charge Transfer Based Narrowband Deep Blue Organic Fluorescence Emitters with EQE > 20% and CIEy ≈ 0.04
The development of multiple-resonance (MR) thermally activated delayed fluorescence (TADF) emitters has attracted considerable attention for the development of next-generation deep-blue organic light-emitting diodes (OLEDs) due to their high exciton utilization efficiency and narrowband emission. Nevertheless, their intrinsically strong intermolecular interactions lead to tight packing in solid films, inducing the formation of exciplexes or exciton aggregates even at low doping concentrations, which severely degrades both luminescence efficiency and color purity. Therefore, developing effective strategies to fabricate quenching-resistant MR-TADF emitters without compromising color purity has become an urgent and important challenge in the field. In this study, we present novel MR-TADF deep-blue emitters, tBuICzCz and PhICzCz, synthesized by a straightforward two-step reaction that connects carbazole groups with a mono-indolo[3,2,1-jk]carbazole (ICz). This design effectively integrates the MR effect of the mono-ICz core with a long-range charge transfer (LRCT) process between the carbazole and ICz units, effectively balancing narrowband emission and suppressed intermolecular quenching. Consequently, tBuICzCz and PhICzCz exhibit narrowband deep-blue emissions at wavelengths of 444 nm and 425 nm, respectively, and demonstrate notable TADF characteristics in the films. The fabricated deep-blue OLEDs based on tBuICzCz and PhICzCz with 15 wt% doping-ratios achieve external quantum efficiency (EQE) values of 24.7% and 15.5%, full width at half-maximum (FWHM) values of 24 nm and 33 nm, and CIEy values of 0.041 and 0.021, respectively, thereby meeting the BT.2020 CIEy standard. Importantly, even at an increased doping ratio of 25 wt%, the devices maintain a high EQEmax (> 13%) with nearly unchanged emission spectrum, demonstrating favorable concentration tunability for practical applications. These results contribute to a deeper understanding of the correlation between molecular structure and optical properties in ICz-based MR-TADF emitters.
- 15 April 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessMultiple-Resonance Extension and Long-Range Charge Transfer Based Narrowband Deep Blue Organic Fluorescence Emitters with EQE > 20% and CIEy ≈ 0.04
The development of multiple-resonance (MR) thermally activated delayed fluorescence (TADF) emitters has attracted considerable attention for the development of next-generation deep-blue organic light-emitting diodes (OLEDs) due to their high exciton utilization efficiency and narrowband emission. Nevertheless, their intrinsically strong intermolecular interactions lead to tight packing in solid films, inducing the formation of exciplexes or exciton aggregates even at low doping concentrations, which severely degrades both luminescence efficiency and color purity. Therefore, developing effective strategies to fabricate quenching-resistant MR-TADF emitters without compromising color purity has become an urgent and important challenge in the field. In this study, we present novel MR-TADF deep-blue emitters, tBuICzCz and PhICzCz, synthesized by a straightforward two-step reaction that connects carbazole groups with a mono-indolo[3,2,1-jk]carbazole (ICz). This design effectively integrates the MR effect of the mono-ICz core with a long-range charge transfer (LRCT) process between the carbazole and ICz units, effectively balancing narrowband emission and suppressed intermolecular quenching. Consequently, tBuICzCz and PhICzCz exhibit narrowband deep-blue emissions at wavelengths of 444 nm and 425 nm, respectively, and demonstrate notable TADF characteristics in the films. The fabricated deep-blue OLEDs based on tBuICzCz and PhICzCz with 15 wt% doping-ratios achieve external quantum efficiency (EQE) values of 24.7% and 15.5%, full width at half-maximum (FWHM) values of 24 nm and 33 nm, and CIEy values of 0.041 and 0.021, respectively, thereby meeting the BT.2020 CIEy standard. Importantly, even at an increased doping ratio of 25 wt%, the devices maintain a high EQEmax (> 13%) with nearly unchanged emission spectrum, demonstrating favorable concentration tunability for practical applications. These results contribute to a deeper understanding of the correlation between molecular structure and optical properties in ICz-based MR-TADF emitters.
- Top Cited PapersOpen Access
- 20 February 2026
- Published by Royal Society of Chemistry (RSC) in Chemical Science
- Vol. 17 (16) , 8061-8075
Zero-trigger ultrafast charge-transfer J-aggregates via Se/π-directed assembly enable synchronous ROS/heat amplification for NIR-II photoimmunotherapy
Supramolecular J-aggregation of π-conjugated photosensitizers provides a powerful strategy to optimize phototheranostic performance.
- 20 February 2026
- Published by Royal Society of Chemistry (RSC) in Chemical Science
- Vol. 17 (16) , 8061-8075
Top Cited PapersOpen AccessZero-trigger ultrafast charge-transfer J-aggregates via Se/π-directed assembly enable synchronous ROS/heat amplification for NIR-II photoimmunotherapy
Supramolecular J-aggregation of π-conjugated photosensitizers provides a powerful strategy to optimize phototheranostic performance.
- 17 May 2024
- Published by Elsevier in Chemical Engineering Journal
- Vol. 493
Zn-Ti oxo cluster photoresists for EUV Lithography: Cluster structure and lithographic performance
- 17 May 2024
- Published by Elsevier in Chemical Engineering Journal
- Vol. 493
Zn-Ti oxo cluster photoresists for EUV Lithography: Cluster structure and lithographic performance
- 13 February 2024
- Published by Elsevier in Chinese Chemical Letters
- Vol. 35 (12)
Se-substituted pentamethine cyanine for anticancer photodynamic therapy mediated using the hot band absorption process
- 13 February 2024
- Published by Elsevier in Chinese Chemical Letters
- Vol. 35 (12)
Se-substituted pentamethine cyanine for anticancer photodynamic therapy mediated using the hot band absorption process
- Open Access
- 18 November 2023
- Published by SAGE Publications in Cancer Biomarkers
- Vol. 42 (1) , 1-11
A clinical spectrum of resectable lung adenocarcinoma with micropapillary component (MPC) concurrently presenting as mixed ground-glass opacity nodules
Background: In clinical practice, preoperative identification of mixed ground-glass opacity (mGGO) nodules with micropapillary component (MPC) to facilitate the implementation of individualized therapeutic strategies and avoid unnecessary surgery is increasingly important Objective: This study aimed to build a predictive model based on clinical and radiological variables for the early identification of MPC in lung adenocarcinoma presenting as mGGO nodules. Methods: The enrolled 741 lung adenocarcinoma patients were randomly divided into a training cohort and a validation cohort (3:1 ratio). The pathological specimens and preoperative images of malignant mGGO nodules from the study subjects were retrospectively reviewed. Furthermore, in the training cohort, selected clinical and radiological variables were utilized to construct a predictive model for MPC prediction. Results: The MPC was found in 228 (43.3%) patients in the training cohort and 72 (41.1%) patients in the validation cohort. Based on the predictive nomogram, the air bronchogram was defined as the most dominant independent risk factor for MPC of mGGO nodules, followed by the maximum computed tomography (CT) value ( > 200), adjacent to pleura, gender (male), and vacuolar sign. The nomogram demonstrated good discriminative ability with a C-index of 0.783 (95%[CI] 0.744–0.822) in the training cohort and a C-index of 0.799 (95%[CI] 0.732–0.866) in the validation cohort Additionally, by using the bootstrapping method, this predictive model calculated a corrected AUC of 0.774 (95% CI: 0.770–0.779) in the training cohort. Conclusions: This study proposed a predictive model for preoperative identification of MPC in known lung adenocarcinomas presenting as mGGO nodules to facilitate individualized therapy. This nomogram model needs to be further externally validated by subsequent multicenter studies.
- 18 November 2023
- Published by SAGE Publications in Cancer Biomarkers
- Vol. 42 (1) , 1-11
Open AccessA clinical spectrum of resectable lung adenocarcinoma with micropapillary component (MPC) concurrently presenting as mixed ground-glass opacity nodules
Background: In clinical practice, preoperative identification of mixed ground-glass opacity (mGGO) nodules with micropapillary component (MPC) to facilitate the implementation of individualized therapeutic strategies and avoid unnecessary surgery is increasingly important Objective: This study aimed to build a predictive model based on clinical and radiological variables for the early identification of MPC in lung adenocarcinoma presenting as mGGO nodules. Methods: The enrolled 741 lung adenocarcinoma patients were randomly divided into a training cohort and a validation cohort (3:1 ratio). The pathological specimens and preoperative images of malignant mGGO nodules from the study subjects were retrospectively reviewed. Furthermore, in the training cohort, selected clinical and radiological variables were utilized to construct a predictive model for MPC prediction. Results: The MPC was found in 228 (43.3%) patients in the training cohort and 72 (41.1%) patients in the validation cohort. Based on the predictive nomogram, the air bronchogram was defined as the most dominant independent risk factor for MPC of mGGO nodules, followed by the maximum computed tomography (CT) value ( > 200), adjacent to pleura, gender (male), and vacuolar sign. The nomogram demonstrated good discriminative ability with a C-index of 0.783 (95%[CI] 0.744–0.822) in the training cohort and a C-index of 0.799 (95%[CI] 0.732–0.866) in the validation cohort Additionally, by using the bootstrapping method, this predictive model calculated a corrected AUC of 0.774 (95% CI: 0.770–0.779) in the training cohort. Conclusions: This study proposed a predictive model for preoperative identification of MPC in known lung adenocarcinomas presenting as mGGO nodules to facilitate individualized therapy. This nomogram model needs to be further externally validated by subsequent multicenter studies.